Turmeric and herb combo may boost ulcerative colitis treatment
NCT ID NCT07240168
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether adding CurQD, a mix of curcumin and QingDai, helps people with active ulcerative colitis who are already taking vedolizumab. Researchers will review records from 400 patients to see if the supplement helps them stay on vedolizumab longer and improves symptoms and biomarkers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CurQD (curcumin and QingDai combination)
- What this could lead to
- If it works, adding CurQD could help people with ulcerative colitis control their disease better and stay on vedolizumab longer.
- What could go wrong
- This is a retrospective study using existing records, not a controlled experiment. Results may be influenced by other factors, and the supplement's benefits are not proven yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Evinature
Binyamina, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- A simple hospital checklist could flag hidden malnutrition in kids with IBD
- Can a new pill tame ulcerative colitis Flare-Ups?
- Could a new pill tame ulcerative colitis? a First-in-Human trial aims to find out
- Can a new pill tame ulcerative colitis when others fail?
- Can a pill tame ulcerative colitis? new trial seeks answers